Cargando…
Application of Non-Blood-Derived Fluid Biopsy in Monitoring Minimal Residual Diseases of Lung Cancer
Lung cancer is one of the most fatal malignant tumors in the world. Overcoming this disease is difficult due to its late diagnosis and relapse after treatment. Minimal residual disease (MRD) is described as the presence of free circulating tumor cells or other tumor cell derivatives in the biologica...
Autores principales: | Yan, Xing, Liu, Changhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149287/ https://www.ncbi.nlm.nih.gov/pubmed/35651679 http://dx.doi.org/10.3389/fsurg.2022.865040 |
Ejemplares similares
-
The value of completion residual lung resection in ipsilateral recurrent non-small cell lung cancer
por: Yang, Yong, et al.
Publicado: (2022) -
Lung Biopsy With a Non-intubated VATS Approach in an Obese Population: Indications and Results
por: Cherchi, Roberto, et al.
Publicado: (2022) -
Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma
por: GOZZETTI, ALESSANDRO, et al.
Publicado: (2023) -
Breast Metastasis of Lung Cancer After Computed Tomography-Guided Core Needle Biopsy: A Case Report
por: Zhao, Rong, et al.
Publicado: (2022) -
Fluorescence-guided lung nodule identification during minimally invasive lung resections
por: Tajè, Riccardo, et al.
Publicado: (2022)